IRADIMED CORP Cash And Cash Equivalents At Carrying Value

Quick Answer

IRADIMED CORP reported Cash And Cash Equivalents At Carrying Value of $51.16 million for the year ending 2025.

  • IRADIMED CORP showed a decrease of -2.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from IRADIMED CORP's annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), IRADIMED CORP's Cash And Cash Equivalents At Carrying Value has grown by 2,914.1%.
  • Historical annual values: Fiscal year 2025: $51.16 million | Fiscal year 2024: $52.23 million | Fiscal year 2023: $49.76 million | Fiscal year 2022: $57.96 million | Fiscal year 2021: $62.00 million | Fiscal year 2020: $50.07 million | Fiscal year 2019: $43.48 million | Fiscal year 2018: $28.03 million | Fiscal year 2017: $18.21 million | Fiscal year 2016: $17.71 million | Fiscal year 2015: $19.37 million | Fiscal year 2014: $9.45 million | Fiscal year 2013: $2.46 million | Fiscal year 2012: $1.70 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: